Tellgen Corporation researches and develops, manufactures, and distributes IVDs in China and internationally. It offers tumor markers, human papilloma virus test kits, ToRCH products, Y chromosome microdeletions test kits, and multiplex immunoassay systems. The company was founded in 2003 and is based in Shanghai, China.
Stock data | 2024 | Change |
---|---|---|
Price | $1.82 | N/A |
Market Cap | $298.05M | N/A |
Shares Outstanding | 164.13M | N/A |
Employees | 710.00 | N/A |